Cavendish Bio

Cavendish Bio

卡文迪许生物

Cavendish Bio

Biotech/Healthcare

Cavendish Bio is an innovative drug developer dedicated to the R&D of novel drug technologies, MAH (Marketing Authorization Holder) manufacturing, and academic promotion services for its developed drugs. Key development areas include anti-tumor drugs (hematologic diseases), diabetes drugs…

Latest round: Series A (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.